WCM/BNY Mellon Focused Growth
|
- Description
- Performance
- Comps
Fundamentals
Valuation
Rating
WCM / BNY Mellon Focused Growth ADR ETF is an actively managed exchange-traded fund incorporated in the USA. The Fund's objective is long-term capital appreciation above international benchmarks such as the BNY Mellon Classic ADR Index and the MSCI EAFE Index. The fund invests in a concentrated, high-quality, large-cap growth portfolio for the non-U.S. universe. |
Category | International Equities |
Fund Sponsor | AdvisorShares Trust |
Website | |
Inception date | Jul 21, 2010 |
Assets (mns) | $105 |
Currency | USD |
Expense ratio | 110 bp |
Distributions | Quarterly |
Regulation | Open-Ended Fund |
Custodian | Bank of New York Mellon |
Weighting | Proprietary |
Index replication | n/a |
Uses derivatives | No |
Options available | No |
No. of constituents | 38 |
Wgt avg mkt cap (mns) | $50,770 |
Large cap (>$10bn) | 59.6% |
Mid cap ($2-10bn) | 37.9% |
Small cap (<$2bn) | 2.5% |
Developed mkts | 61.6% |
Emerging mkts | 38.4% |
GALAPAGOS NV SPONSORED ADR | 5.1 % |
NICE SYSTEMS LTD-SPONS ADR | 4.8 % |
ARGENX SE ADR | 3.7 % |
AIRBUS GROUP NV - UNSP ADR | 3.6 % |
MERCADOLIBRE INC | 3.5 % |
ALLEGION PLC | 3.4 % |
LVMH MOET HENNESSY-UNSP ADR | 3.3 % |
COSAN LTD-CLASS A SHARES | 3.3 % |
ANGLOGOLD ASHANTI-SPON ADR | 3.3 % |
GOLD FIELDS LTD-SPONS ADR | 2.9 % | Total | 36.9 % |
---|
![]() |
NETHERLANDS | 14.3 % |
![]() |
IRELAND | 13.9 % |
![]() |
BRAZIL | 10.0 % |
![]() |
SOUTH AFRICA | 8.5 % |
![]() |
CHINA | 8.0 % |
![]() |
BRITAIN | 7.7 % |
![]() |
INDIA | 6.9 % |
![]() |
BELGIUM | 5.3 % |
![]() |
SWITZERLAND | 5.2 % |
![]() |
ISRAEL | 4.8 % |
HISTORICAL PERFORMANCE 

Custom date range | Compare to | ||
thru |
Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
27.3% | 15.4% | 6.5% | -- | 8.5% |
versus... | Beta | R-squared |
S&P500 | 0.96 | 42% |
MSCI EAFE | 1.22 | 56% |
MSCI Emg. Mkts. | 0.95 | 54% |
Recent close | $51.38 |
30d moving avg. | $50.26 |
Annualized volatility | 18.0% |
Short interest (ETF) | 0.1% |
Short interest (Underlying) | 1.5% |
Relative strength (RSI) | 73 |
Avg. volume (thou.) | 8 |
Turnover | 0.4% |
Bid/Ask (% of price) | 0.41% |
ADV underlying (mns) | $2,395 |
FINDING ALTERNATIVE FUNDS
Below is a list of 20 potential alternatives to the WCM/BNY Mellon Focused Growth ETF based on the alternatives' overlap in portfolio holdings with AADR. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
Benchmark ticker: | AADR | Expense: | 110 bp | ALTAR Score™: | 3.1% |
Ticker | Fund Name |
Overlap1 vs AADR (%) |
Expense ratio (bp) |
Savings vs AADR (bp) |
ALTAR Score™ (%) |
ALTAR vs AADR (%) |
ADRU | BLDRs Europe 100 ADR | 15.2 | 30 | 80 | 8.1 | +5.0 |
ADRD | BLDRs Developed Markets 100 ADR | 14.6 | 30 | 80 | 9.0 | +5.9 |
FNI | First Trust ISE Chindia | 12.4 | 59 | 51 | 4.0 | +0.9 |
EEB | Invesco BRIC | 12.4 | 64 | 46 | 6.6 | +3.6 |
ADRE | BLDRs Emerging Markets 50 ADR | 9.3 | 30 | 80 | 6.4 | +3.3 |
BICK | First Trust BICK Index Fund | 9.3 | 64 | 46 | 5.6 | +2.5 |
KEMQ | KraneShares EM Consumer Focus | 8.5 | 80 | 30 | 7.8 | +4.7 |
XCEM | Columbia EM Core ex-China | 8.4 | 16 | 94 | 7.6 | +4.5 |
PGJ | Invesco Golden Dragon China | 7.9 | 70 | 40 | 3.7 | +0.7 |
ACT | AdvisorShares Vice | 7.6 | 99 | 11 | 7.9 | +4.9 |
AIIQ | AI Powered International Equity | 7.3 | 79 | 31 | 4.6 | +1.5 |
CNCR | Loncar Cancer Immunotherapy | 6.5 | 79 | 31 | -3.5 | -6.5 |
ADRA | BLDRs Asia 50 ADR | 6.3 | 30 | 80 | 9.2 | +6.1 |
GDX | VanEck Vectors Gold Miners ETF | 5.7 | 52 | 58 | 2.4 | -0.7 |
ECOW | Pacer Emerging Markets Cash Cows 100 | 5.5 | 70 | 40 | 10.9 | +7.8 |
PIE | Invesco DWA Emg. Mkts. Technical Leaders | 5.3 | 90 | 20 | 5.2 | +2.1 |
PID | Invesco International Dividend Achievers | 5.2 | 54 | 56 | 7.4 | +4.3 |
PPH | VanEck Vectors Pharmaceuticals | 5.1 | 36 | 74 | 9.4 | +6.4 |
GDXJ | VanEck Vectors Jr. Gold Miners | 5.1 | 53 | 57 | 2.4 | -0.7 |
CHIQ | Global X MSCI China Consumer Discretionary | 5.1 | 65 | 45 | 5.3 | +2.2 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | |
---|---|---|---|---|---|---|---|
Sales per share | ** | ** | ** | ** | ** | ** | ** |
Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share ![]() |
** | ** | ** | ** | ** | ** | ** |
Book value per share | ** | ** | ** | ** | ** | ** | ** |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
Long term EPS growth est. | **% | Debt-to-equity | **x | |
Asset turnover | **% | Assets-to-equity | **x |
*Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
2018 | 2019E | 2020E | |
---|---|---|---|
Price-to-sales | ** | ** | ** |
Price-to-earnings | ** | ** | ** |
Price-to-cash flow | ** | ** | ** |
Price-to-growth | ** | ** | ** |
Price-to-book value | ** | ** | ** |
Yield | ** | ** | ** |
Historical valuation trends
Forward multiple: |
WCM/BNY Mellon Focused Growth | |||
Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
ALTAR Score™
|
MODERN PORTFOLIO THEORY
![]() |
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|